Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kapitsa Ig"'
Publikováno v:
Moscow University Biological Sciences Bulletin. 75:89-95
Both male and female Wistar rats with an experimental model of autism spectrum disorders induced by prenatal administration of valproate sodium at a dose of 500 mg/kg have behavioral abnormalities similar to people with these disorders, including the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd82ab3f537cc2ee1faa708f82f7280f
https://doi.org/10.3103/s0096392520020054
https://doi.org/10.3103/s0096392520020054
Publikováno v:
Moscow University Biological Sciences Bulletin. 74:69-74
Prolyl endopeptidase is involved in neurodegeneration, proliferation, neuroinflammation, and neuron differentiation. It has been observed that severity of the neurodegenerative process correlates with an increasing level of prolyl endopeptidase in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eb1cf6ba003bceab121283bee582163
https://doi.org/10.3103/s0096392519020044
https://doi.org/10.3103/s0096392519020044
Autor:
E.A. Valdman, L.N. Nerobkova, Kapitsa Ig, T.A. Voronina, I.I. Kokschenev, K. B. Kurakhmaeva, A. Nepoklonov
Publikováno v:
European Neuropsychopharmacology. 21:S120-S121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd2f515bfaadd18dbe1864d4d4666926
https://doi.org/10.1016/s0924-977x(11)70132-8
https://doi.org/10.1016/s0924-977x(11)70132-8
Publikováno v:
European Neuropsychopharmacology. 24:S222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::172f435e07897a0261b23f0e879c6b3e
https://doi.org/10.1016/s0924-977x(14)70344-x
https://doi.org/10.1016/s0924-977x(14)70344-x
P.5.007 Perspectives of the use of a new antioxidant mexidol in the treatment of Parkinson's disease
Autor:
E A Katunina, L.N. Nerobkova, Malykhina Ea, Kapitsa Ig, G.N. Avakyan, T.A. Voronina, R.K. Arakelyan
Publikováno v:
European Neuropsychopharmacology. 15:S203-S204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3038914c82ac93c51838510741a8d38e
https://doi.org/10.1016/s0924-977x(05)80409-2
https://doi.org/10.1016/s0924-977x(05)80409-2
P.1.007 Protective effect of the antiparkinsonian drug hemantane in an MPTP model using C57BL/6 mice
Publikováno v:
European Neuropsychopharmacology. 21:S120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a9c5d2db876b6b2e738b4eab617104
https://doi.org/10.1016/s0924-977x(11)70131-6
https://doi.org/10.1016/s0924-977x(11)70131-6
Publikováno v:
European Neuropsychopharmacology. 21:S154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55db51b7c7d3d444808d24b20db94a95
https://doi.org/10.1016/s0924-977x(11)70191-2
https://doi.org/10.1016/s0924-977x(11)70191-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Buneeva OA; Institute of Biomedical Chemistry, Moscow, Russia., Kapitsa IG; Institute of Biomedical Chemistry, Moscow, Russia; Zakusov Institute of Pharmacology, Moscow, Russia., Kazieva LS; Institute of Biomedical Chemistry, Moscow, Russia., Vavilov NE; Institute of Biomedical Chemistry, Moscow, Russia., Zgoda VG; Institute of Biomedical Chemistry, Moscow, Russia., Medvedev AE; Institute of Biomedical Chemistry, Moscow, Russia.
Publikováno v:
Biomeditsinskaia khimiia [Biomed Khim] 2024 Aug; Vol. 70 (4), pp. 231-239.
Autor:
Buneeva OA; Institute of Biomedical Chemistry, Moscow, Russia., Kapitsa IG; Institute of Biomedical Chemistry, Moscow, Russia; Zakusov Institute of Pharmacology, Moscow, Russia., Kazieva LS; Institute of Biomedical Chemistry, Moscow, Russia., Vavilov NE; Institute of Biomedical Chemistry, Moscow, Russia., Zgoda VG; Institute of Biomedical Chemistry, Moscow, Russia., Medvedev AE; Institute of Biomedical Chemistry, Moscow, Russia.
Publikováno v:
Biomeditsinskaia khimiia [Biomed Khim] 2024 Feb; Vol. 70 (1), pp. 25-32.